Ivan Richards has been appointed senior director of pharmacology at Sirna Therapeutics, the company said Nov. 4.
Richards comes to Sirna from Pfizer, and prior to the merger, Pharmacia, where he was a scientist, senior fellow, and discovery team leader.
Ian Gray has been appointed head of research at Paradigm Therapeutics Singapore, a new Singapore R&D subsidiary of the Cambridge, UK-based company.
Get the full story with
GenomeWeb Premium
Only $95 for the
first 90 days*
A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.
Try GenomeWeb Premium now.
Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.
*Before your trial expires, we’ll put together a custom quote with your long-term premium options.
